Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

PhaseBio Pharmaceuticals Q1 EPS $(0.23) Up From $(0.87) YoY

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.23) per share. This is a 73.56 percent increase over losses of $(0.87) per share from the same period last year.
byBenzinga Newsdesk
May 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.23) per share. This is a 73.56 percent increase over losses of $(0.87) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts